Following quantification, IGF1Rβ protein was on average 2.1-fold higher (p<0.001) and c-MYC was about 2.5-fold higher (p<0.02) in Ptp4a3-null relative to wildtype colon tumors (Fig. 4B–C). This evidence concerns the gene PTP4A3 and digestive system neoplasm.